NSENews VerificationRegulatory5d ago
Pfizer Limited
News Verification
Pfizer Limited has temporarily discontinued Premarin Vaginal Cream in India due to supply constraints, contributing less than 1% to the company's revenue. The discontinuation is not expected to have a material impact on the company's financial performance or profitability.
NSENews VerificationRegulatory5d ago
Pfizer Limited
News Verification
The NSE has sought clarification from Pfizer Limited regarding a news article about the company suspending Premarin vaginal cream in India, citing concerns over menopause care.
NSECertificate under SEBI (Depositories and Participants) Regulations, 201810 Jul 2026
Pfizer Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pfizer Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended June 30, 2026.
NSEUpdatesResults7 Jul 2026
Pfizer Limited
Updates
Pfizer Limited has informed the Exchange regarding the 75th Annual General Meeting (AGM) and the Annual Report for the Financial Year ended March 31, 2026. The AGM will be held on July 28, 2026, through video conferencing. The Annual Report is available on the company's website and on the websites of the stock exchanges.
NSECopy of Newspaper PublicationResults7 Jul 2026
Pfizer Limited
Copy of Newspaper Publication
Pfizer Limited has informed the Exchange about Copy of Newspaper Publication for the 75th Annual General Meeting.
NSEShareholders meetingResults6 Jul 2026
Pfizer Limited
Shareholders meeting
Pfizer Limited has informed the Exchange regarding Notice of the 75th Annual General Meeting to be held on July 28, 2026, through Video Conferencing (‘VC’) / Other Audio-Visual Means (‘OAVM’) to transact the following business: To consider and pass the following resolution as an Ordinary Resolution: Item No. 1 – Adoption of the Audited Financial Statements. Item No. 2 – Declaration of Dividend. Item No. 3 – To appoint a Director in place of Mr. P. Rengan (DIN: 10362899) as a Director, liable to retire by rotation. The Board of Directors at its meeting held on May 12, 2026, has recommended a final dividend of Rs. 75/- per equity share of Rs. 10/- each (750%) for the financial year ended March 31, 2026.
NSETrading WindowResults26 Jun 2026
Pfizer Limited
Trading Window
Pfizer Limited has closed its trading window for trading in its shares from June 30, 2026, until 48 hours after the unaudited financial results for the quarter ending June 30, 2026, are made public.